The company
Altimmune, Inc.
ALT · Nasdaq
ALT stood above a rising 150-day average in 2 of the last 52 weekly readings, and has been out of that trend for the last 33 weeks. It is 26.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 33
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $635K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 205 (+41)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 2 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Jerome Benedict DursoPresident and CEO | bought | 15,000at $2.95 | 13 Aug 2026filed 13 Aug 2026 |
| John GillDirector | bought | 9,200at $3.41 | 6 Apr 2026filed 6 Apr 2026 |
| Gregory L. WeaverChief Financial Officer | bought | 10,000at $3.15 | 1 Apr 2026filed 1 Apr 2026 |
| Jerome Benedict DursoPresident and CEO | bought | 15,000at $3.14 | 1 Apr 2026filed 1 Apr 2026 |
| Gregory L. WeaverChief Financial Officer | bought | 5,000at $3.54 | 6 Mar 2026filed 9 Mar 2026 |
| Jerome Benedict DursoPresident and CEO | bought | 20,000at $3.54 | 6 Mar 2026filed 9 Mar 2026 |
| Wayne PisanoDirector | bought | 5,000at $4.08 | 8 Jan 2026filed 9 Jan 2026 |
| Catherine A. SohnDirector | bought | 500at $4.24 | 5 Jan 2026filed 5 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 20,385,284$62.0M | +7,590,007+59.3% |
| Deep Track Capital, LPnew · filed 14 Aug 2026 | 19,250,000$58.5M | +19,250,000 |
| STATE STREET CORPadded · filed 7 Aug 2026 | 12,098,540$36.8M | +4,952,990+69.3% |
| TCG Crossover Management, LLCnew · filed 14 Aug 2026 | 10,000,000$30.4M | +10,000,000 |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 8,177,752$24.9M | +2,519,703+44.5% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 7,330,265$22.3M | +1,948,263+36.2% |
| MARSHALL WACE, LLPadded · filed 13 Aug 2026 | 6,841,055$20.8M | +2,823,154+70.3% |
| VIKING GLOBAL INVESTORS LPnew · filed 14 Aug 2026 | 6,700,000$20.4M | +6,700,000 |
| RA CAPITAL MANAGEMENT, L.P.new · filed 14 Aug 2026 | 6,500,000$19.8M | +6,500,000 |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 5,011,314$15.2M | +1,904,218+61.3% |
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.